Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

Gates, S; Perkins, G; Lamb, S; Kelly, C; Thickett, DR; Young, J; McAuley, D; Snaith, C; McCabe, C; Hulme, C; Gao Smith, F

Journal article

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

Abstract:: BACKGROUND: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care patients and lacks effective treatments. A previous randomised controlled Phase II trial suggested that an intravenous (i.v.) infusion of salbutamol may be beneficial, as it reduced extravascular lung water and plateau airway pressure. The Beta-Agonist Lung injury TrIal-2 (BALTI-2) was initiated to evaluate the effects of this intervention on mortality in patients with ARDS. OBJECTIVES: To e...
Expand abstract
Collapse abstract

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Gates, S., Perkins, G., Lamb, S., Kelly, C., Thickett, D. R., Young, J., McAuley, D., Snaith, C., McCabe, C., Hulme, C., & Gao Smith, F. (2013). Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome. Health Technology Assessment (Winchester, England), 17(38), v-87.

MLA Style

Gates, S., et al. “Beta-Agonist Lung Injury TrIal-2 (BALTI-2): a Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial and Economic Evaluation of Intravenous Infusion of Salbutamol versus Placebo in Patients with Acute Respiratory Distress Syndrome.” Health Technology Assessment (Winchester, England), vol. 17, no. 38, 2013, pp. v-87.

Chicago Style

Gates, S, G Perkins, S Lamb, C Kelly, DR Thickett, J Young, D McAuley, et al. 2013. “Beta-Agonist Lung Injury TrIal-2 (BALTI-2): a Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial and Economic Evaluation of Intravenous Infusion of Salbutamol versus Placebo in Patients with Acute Respiratory Distress Syndrome.” Health Technology Assessment (Winchester, England) 17 (38): v-87.
Tweet
Print